imipramine has been researched along with bethanechol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chun, A; Kato, K; Kitada, S; Levin, RM; Wein, AJ | 1 |
| Wein, AJ | 1 |
| Anderson, W; Dickinson, KE; Hirschowitz, BI; Matsumoto, H; Pruitt, RE; Uemura, N | 1 |
| McGuire, EJ; Savastano, JA | 1 |
2 review(s) available for imipramine and bethanechol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic treatment of lower urinary tract dysfunction in the female patient.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Tricyclic; Bethanechol; Bethanechol Compounds; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Muscle Relaxants, Central; Muscle, Smooth; Parasympatholytics; Phenoxybenzamine; Prazosin; Receptors, Adrenergic; Urethra; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder Neck Obstruction; Urination Disorders; Urologic Diseases | 1985 |
4 other study(ies) available for imipramine and bethanechol
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro intravesical instillation of anticholinergic, antispasmodic and calcium blocking agents (rabbit whole bladder model).
Topics: Administration, Intravesical; Animals; Atropine; Bethanechol; Bethanechol Compounds; Calcium Channel Blockers; Imipramine; Male; Mandelic Acids; Muscle Contraction; Muscle, Smooth; Parasympatholytics; Rabbits; Urinary Bladder; Urinary Bladder, Neurogenic | 1989 |
Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies.
Topics: Acetylcholine; Animals; Atropine; Bethanechol; Bethanechol Compounds; Carbachol; Esophagus; Imipramine; Kinetics; N-Methylscopolamine; Oxotremorine; Pepsinogens; Pirenzepine; Propranolol; Radioligand Assay; Rana catesbeiana; Receptors, Muscarinic; Scopolamine Derivatives | 1988 |
Urodynamic findings and long-term outcome management of patients with multiple sclerosis-induced lower urinary tract dysfunction.
Topics: Adult; Aged; Bethanechol; Bethanechol Compounds; Female; Humans; Imipramine; Male; Mandelic Acids; Middle Aged; Multiple Sclerosis; Muscle Contraction; Muscle, Smooth; Parasympatholytics; Phenoxybenzamine; Reflex, Abnormal; Time Factors; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Catheterization; Urodynamics | 1984 |